243 related articles for article (PubMed ID: 29736616)
1. Cardiac MRI for the evaluation of oncologic cardiotoxicity.
Löffler AI; Salerno M
J Nucl Cardiol; 2018 Dec; 25(6):2148-2158. PubMed ID: 29736616
[TBL] [Abstract][Full Text] [Related]
2. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
[TBL] [Abstract][Full Text] [Related]
3. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.
Soufer A; Liu C; Henry ML; Baldassarre LA
J Nucl Cardiol; 2020 Aug; 27(4):1210-1224. PubMed ID: 30868378
[TBL] [Abstract][Full Text] [Related]
4. Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
Tahir E; Azar M; Shihada S; Seiffert K; Goy Y; Beitzen-Heineke A; Molwitz I; Muellerleile K; Stehning C; Schön G; Adam G; Petersen C; Müller V; Lund GK
Eur Radiol; 2022 Mar; 32(3):1853-1865. PubMed ID: 34536111
[TBL] [Abstract][Full Text] [Related]
5. Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more.
Loar RW; Pignatelli RH; Tunuguntla HP; Rainusso NC; Gramatges MM; Plana JC; Noel CV
Int J Cardiovasc Imaging; 2020 Oct; 36(10):1887-1895. PubMed ID: 32488453
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.
Higgins AY; Arbune A; Soufer A; Ragheb E; Kwan JM; Lamy J; Henry M; Cuomo JR; Charifa A; Gallegos C; Hull S; Coviello JS; Bader AS; Peters DC; Huber S; Mojibian HR; Sinusas AJ; Kluger H; Baldassarre LA
PLoS One; 2021; 16(2):e0246764. PubMed ID: 33606757
[TBL] [Abstract][Full Text] [Related]
7. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Role of Echocardiography for Clinical Decision Making in Patients During and After Cancer Therapy.
Liu J; Banchs J; Mousavi N; Plana JC; Scherrer-Crosbie M; Thavendiranathan P; Barac A
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1122-1131. PubMed ID: 30092969
[TBL] [Abstract][Full Text] [Related]
9. Can global longitudinal strain (GLS) with magnetic resonance prognosticate early cancer therapy-related cardiac dysfunction (CTRCD) in breast cancer patients, a prospective study?
Kar J; Cohen MV; McQuiston SA; Malozzi CM
Magn Reson Imaging; 2023 Apr; 97():68-81. PubMed ID: 36581216
[TBL] [Abstract][Full Text] [Related]
10. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients.
Terui Y; Sugimura K; Ota H; Tada H; Nochioka K; Sato H; Katsuta Y; Fujiwara J; Harada-Shoji N; Sato-Tadano A; Morita Y; Sun W; Higuchi S; Tatebe S; Fukui S; Miyamichi-Yamamoto S; Suzuki H; Yaoita N; Kikuchi N; Sakota M; Miyata S; Sakata Y; Ishida T; Takase K; Yasuda S; Shimokawa H
Int J Cardiol; 2023 Jan; 371():472-479. PubMed ID: 36115441
[TBL] [Abstract][Full Text] [Related]
12. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy].
Charbonnel C
Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of Myocardial Work Indices for Identification of Cancer Therapy-Related Cardiotoxicity.
Calvillo-Argüelles O; Thampinathan B; Somerset E; Shalmon T; Amir E; Steve Fan CP; Moon S; Abdel-Qadir H; Thevakumaran Y; Day J; Woo A; Wintersperger BJ; Marwick TH; Thavendiranathan P
JACC Cardiovasc Imaging; 2022 Aug; 15(8):1361-1376. PubMed ID: 35926895
[TBL] [Abstract][Full Text] [Related]
14. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment.
Wengrofsky P; Feldman S
Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535
[TBL] [Abstract][Full Text] [Related]
15. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
[TBL] [Abstract][Full Text] [Related]
16. Echocardiography and cancer therapeutics-related cardiac dysfunction.
Tanaka H
J Med Ultrason (2001); 2019 Jul; 46(3):309-316. PubMed ID: 31030300
[TBL] [Abstract][Full Text] [Related]
17. Cancer Therapeutics-Related Cardiac Dysfunction among Patients with Active Breast Cancer: A Cardio-Oncology Registry.
Laufer-Perl M; Mor L; Milwidsky A; Derakhshesh M; Amrami N; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Rozenbaum Z
Isr Med Assoc J; 2020 Sep; 22(9):564-568. PubMed ID: 33236555
[TBL] [Abstract][Full Text] [Related]
18. Can post-chemotherapy cardiotoxicity be detected in long-term survivors of breast cancer via comprehensive 3D left-ventricular contractility (strain) analysis?
Kar J; Cohen MV; McQuiston SA; Figarola MS; Malozzi CM
Magn Reson Imaging; 2019 Oct; 62():94-103. PubMed ID: 31254595
[TBL] [Abstract][Full Text] [Related]
19. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
[TBL] [Abstract][Full Text] [Related]
20. [Cardiooncology-usefulness of cardiac MRI : Inflammation, fibrosis, outcome].
Erley J; Beitzen-Heineke A; Tahir E
Radiologie (Heidelb); 2022 Nov; 62(11):941-946. PubMed ID: 35969245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
